Global real-world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Global real-world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts

Mangia A, Milligan S, Khalili M, et al. Global real-world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts. International Liver Congress. Vienna, Austria; 2019.

Publication Type:

Conference Proceedings

Authors:

Mangia, A; Milligan, S; Khalili, M; et, al

Source:

International Liver Congress, Vienna, Austria (2019)

Cited On:

Treatment-Naive Genotype 3 Without Cirrhosis

Export Citation:

RIS Format

Top